DMCC Speciality Chemicals share price today

DMCC Speciality Chemicals Ltd's share price was ₹241.50 at the close on 4 November 2026. It has been rising for 11 weeks. That is 13.8% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹207 and ₹333, and at that close it sat 28% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today DMCC Speciality Chemicals Ltd is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 2 weeks running.

Over the last 11 years the share price moved +316% while the NIFTY 500 moved +251%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 23 October 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

1. Lowest operating margin in 15 quarters

   Operating margin was 4.2% in the September 2026 quarter, against 11.1% a year earlier.

3. Profit fell in the September 2026 quarter

   Profit was ₹3 crore, -43.8% on a year earlier (₹6 crore), after 2 quarters of growth.

For July to September 2026 (the quarter ended 30 September 2026), DMCC Speciality Chemicals reported revenue of ₹273 crore, up 116.5% from ₹126 crore a year earlier, and a profit of ₹3.23 crore, down 43.8% from ₹5.75 crore.

DMCC Speciality Chemicals results: July to September 2026 against a year earlier

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

The newest call in our records is from 19 May 2026, about January to March 2026; a call about these results is not in our records yet.

From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.

DMCC Speciality Chemicals closed at ₹241.50 on 4 November 2026, down 17.4% from ₹292.30 a year earlier (7 November 2025) and down 26.5% over five years. Its highest weekly close since March 2016 was ₹441.80 on 13 April 2022.

DMCC Speciality Chemicals share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

563 weekly closes from 11 March 2016 to 4 November 2026.

4 Nov 2026: DMCC Speciality Chemicals closed at ₹241.50, down 5.0% on the week and down 22.1% on the month. Our read, 10 Oct 2026: DMCC has an earnings recovery to verify, but supplier financing and commodity price pass-through prevent treating the revenue surge as a proven specialty transformation.

Earlier

• Results for July to September 2026: Revenue up 116.5% and profit down 43.8% on a year earlier.
• 21 Aug 2026: ex-date for a dividend of ₹2.50 a share.
• 19 May 2026: DMCC Speciality Chemicals held its results call for January to March 2026. Management guided: Specialty chemicals commercialization expected FY27-FY28 - boron specialty products and enhanced oil recovery polymer moving to commercial stage with limited early sales already initiated; scale and margin profile unknown.

Our read of the business

April to June 2026: Operating profit rises; the latest available call predates the result.

Our read after the April to June 2026 results, written 10 October 2026. The July to September 2026 results are out since, so this part may be out of date until we update it.

DMCC Speciality Chemicals paid ₹2.50 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 1.04% at the ₹241.50 close on 4 November 2026. The last was a dividend of ₹2.50 a share, ex-date 21 August 2026.

DMCC Speciality Chemicals dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.

Yes. DMCC Speciality Chemicals Ltd paid out 23% of its profit as dividends in FY26, and it paid a dividend in 7 of its last 10 reported years.

From the NSE corporate-actions record, read 5 November 2026.

On the call for January to March 2026, held on 19 May 2026, DMCC Speciality Chemicals' management guided: Specialty chemicals commercialization expected FY27-FY28 - boron specialty products and enhanced oil recovery polymer moving to commercial stage with limited early sales already initiated; scale and margin profile unknown.

“While we did not expand our margins, we did manage to pass on all the price increases to our customers. Mathematically, it looks in percentage terms as if the margin has come down, but in absolute terms - even in a turbulent and difficult supply chain situation - we were able to maintain the absolute margin.”Bimal Gokhaldas, on the call for January to March 2026

What management guided

• Capacity utilization expected to improve from FY26.
• R&D spending to increase materially in coming quarters shifting from historical ₹2 crore run rate focused on process improvement.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for January to March 2026, 19 May 2026. The July to September 2026 results are out since, so this part may be out of date until we update it.

What is changing at DMCC Speciality Chemicals, from the latest results and calls: boron production restoration, replacement export relationships and delayed specialty cost recovery.

• Boron production restoration. Restored raw-material availability allows lost boron business to return, subject to end-customer demand. ⚠ estimate
• Replacement export relationships. Latin American commercial relationships have reportedly replaced most lost European business. ⚠ estimate
• Delayed specialty cost recovery. Quarterly contract repricing can recover specialty input costs after a timing lag. ⚠ estimate
• Specialty product commercialization. Early sales establish a product pipeline, but its earnings scale remains unknown. ✓ fact

We check 16 kinds of change in every company, such as costs spread over more sales, higher-value products, new orders, new regions or falling debt, against its reported numbers and what management said on its calls. Only changes the numbers back are shown.

Our read after the April to June 2026 results, written 10 October 2026. The July to September 2026 results are out since, so this part may be out of date until we update it.

Further earnings growth accompanied by continuing negative operating cash flow after management reports supply normalization would break the thesis that this is a recoverable supplier-financing disruption rather than growth dependent on permanent borrowing.

Each change stops working if

• Boron production restoration: Boron supply interruptions recur or customers continue liquidating stock despite restored production.
• Replacement export relationships: Replacement customers fail to reorder or their contribution margins do not cover the European business lost.
• Delayed specialty cost recovery: Contract resets fail to recover costs or customer demand falls enough to offset recovered contribution.
• Specialty product commercialization: Product acceptance remains unquantified through the disclosed commercialization window.

The main risks

• : Supplier-credit withdrawal has turned accounting profit into borrowing-funded working capital. ⚠ estimate
• : Imported sulfur and Turkish boron remain physical supply dependencies. ⚠ estimate
• : Commodity inflation can raise reported sales while shrinking customer consumption. ⚠ estimate
• : Replacement exports face competition while additional domestic acid supply remains a threat. ⚠ estimate

Our read after the April to June 2026 results, written 10 October 2026. The July to September 2026 results are out since, so this part may be out of date until we update it.

When DMCC Speciality Chemicals reports October to December 2026, these are the 4 checks that show whether the story is still on course. First: Working capital as percentage of sales to remain at or below two months of sales metric - management stated current ratio healthy and should normalize once boron supply terms and sulfur prices stabilize; reduction from expanded current absolute rupee level signals supply chain normalization.

DMCC Speciality Chemicals is on 2 of our India lists: Multibagger study list and Undervalued stocks.

DMCC Speciality Chemicals Ltd earned ₹3.2 Cr of net profit in the Sep 2026 quarter, −43.8% on the same quarter a year earlier. Full-year FY26 profit was ₹27.0 Cr. Over 9 years profit has grown 5.3% a year on average. That is 1.2% of the quarter's revenue. The same quarter a year earlier earned ₹5.8 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹27.0 Cr (+22.7% on the year before).

Why profit moved: revenue changed +116.5% on a year earlier and the margin moved −6.9 percentage points. Sales did the work while the margin got thinner.

On average over the last four quarters, profit changed +28.9% and revenue +71.3%. Profit is growing slower than sales: rising costs are taking part of the growth.

FY26-Q4. Price pass-through lifts sales while procurement absorbs cash

Why-sources: our stock research file (10 October 2026) and the company’s own results for those quarters.

DMCC Speciality Chemicals Ltd reported ₹273 Cr of revenue in the Sep 2026 quarter, +116.5% on the same quarter a year earlier. That is the 9th quarter in a row with growth on the year before. Over 9 years it has grown 14.3% a year on average. The last full year, FY26, came in at ₹582 Cr.

Revenue is everything the company billed its customers in the period.

Why this happened. Management reports production restoration after the supplier transition. This addresses a physical bottleneck, but gas-constrained customers remain a separate demand bottleneck. Production, utilization and recovered sales are one dependent mechanism; they do not justify separate additive profit uplifts. The first financial contribution is not isolated in the reported segment data, and its persistence depends on supply continuity and customer consumption.

The last four reported quarters add to ₹854 Cr.

FY26 revenue was ₹582 Cr, +35.0% on the year before.

Recent pace: the last four quarters grew +71.3% on average, against 14.3% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +72.1%, against +55.7% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +34.5%, against +68.1% a year (rolling over).

FY26-Q4. Price pass-through lifts sales while procurement absorbs cash

Why-sources: our stock research file (10 October 2026) and the company’s own results for those quarters.

DMCC Speciality Chemicals Ltd's operating margin was 4.2% in the Sep 2026 quarter, 6.9 percentage points lower than the same quarter a year ago. Across 10 years it has been between 9.0% and 24.0%. The latest quarter is below every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why this happened. The Input Cost Pass-Through Test distinguishes recovery of input costs from an increase in unit profitability. Management says specialty costs are incurred before contract prices reset. A later margin recovery is therefore plausible, but customers may reduce consumption and competitors may constrain realizations.

Why the margin moved: operating margin changed −6.9 percentage points on the year while gross margin changed −16.4 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

FY26-Q4. Price pass-through lifts sales while procurement absorbs cash

Why-sources: our stock research file (10 October 2026) and the company’s own results for those quarters.

Over the last 3 years, 95% of DMCC Speciality Chemicals Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 its operations used ₹18.0 Cr of cash, against ₹27.0 Cr of profit.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

After ₹7.0 Cr of spending on assets, free cash was −₹25.0 Cr: it spent more than its operations brought in.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 95% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle.

What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets.

DMCC Speciality Chemicals Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 83 days in FY26, down from 92 days in FY21. It spent ₹33.0 Cr on assets over the last 3 years. Customers take 60 days to pay, and stock sits for 82 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹582 Cr, each day of that cycle ties up about ₹1.6 Cr, so roughly ₹132 Cr is tied up in the business at any time.

FY26: customers took 60 days to pay and stock sat for 82 days, about 2.7 months of sales sitting as stock, for a full cycle of 83 days, shorter than FY21's 92.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 82 days. Customers pay about 60 days after that. Suppliers are paid at 60 days. Together that makes the 83-day cycle.

Spending on assets: ₹33.0 Cr over the last 3 years, against ₹49.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is spending about what it takes to replace what wears out, or less. Work still in progress is ₹5.0 Cr (FY26): assets paid for that are not earning yet.

In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean.

DMCC Speciality Chemicals Ltd's P/E is 16.1×, near the low end of its own history: it has been lower only 21% of the time. Its usual P/E (the middle reading) is 28.4×, over 8.9 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.